These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 15899983)
1. Signaling through CD16b in human neutrophils involves the Tec family of tyrosine kinases. Fernandes MJ; Lachance G; Paré G; Rollet-Labelle E; Naccache PH J Leukoc Biol; 2005 Aug; 78(2):524-32. PubMed ID: 15899983 [TBL] [Abstract][Full Text] [Related]
2. 5-Hydroxy-7-methoxyflavone inhibits N-formyl-L-methionyl-L-leucyl-L-phenylalanine-induced superoxide anion production by specific modulate membrane localization of Tec with a PI3K independent mechanism in human neutrophils. Liao HR; Chen JJ; Chien YH; Lin SZ; Lin S; Tseng CP Biochem Pharmacol; 2012 Jul; 84(2):182-91. PubMed ID: 22484311 [TBL] [Abstract][Full Text] [Related]
3. Role of different protein tyrosine kinases in fMLP-induced neutrophil transmigration. Zen K; Liu Y Immunobiology; 2008; 213(1):13-23. PubMed ID: 18207024 [TBL] [Abstract][Full Text] [Related]
4. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. Gilbert C; Levasseur S; Desaulniers P; Dusseault AA; Thibault N; Bourgoin SG; Naccache PH J Immunol; 2003 May; 170(10):5235-43. PubMed ID: 12734372 [TBL] [Abstract][Full Text] [Related]
5. The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity. van den Akker E; van Dijk TB; Schmidt U; Felida L; Beug H; Löwenberg B; von Lindern M Biol Chem; 2004 May; 385(5):409-13. PubMed ID: 15196000 [TBL] [Abstract][Full Text] [Related]
6. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase. Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369 [TBL] [Abstract][Full Text] [Related]
7. The involvement of phospholipase C in crystal induced human neutrophil activation. Jackon JK; Tudan C; Burt HM J Rheumatol; 2000 Dec; 27(12):2877-85. PubMed ID: 11128680 [TBL] [Abstract][Full Text] [Related]
8. Tec protein tyrosine kinase inhibits CD25 expression in human T-lymphocyte. Susaki K; Kitanaka A; Dobashi H; Kubota Y; Kittaka K; Kameda T; Yamaoka G; Mano H; Mihara K; Ishida T Immunol Lett; 2010 Jan; 127(2):135-42. PubMed ID: 19883687 [TBL] [Abstract][Full Text] [Related]
9. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidynositol 3-kinases. Lachance G; Levasseur S; Naccache PH J Biol Chem; 2002 Jun; 277(24):21537-41. PubMed ID: 11940595 [TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase. Uckun FM; Zheng Y; Cetkovic-Cvrlje M; Vassilev A; Lisowski E; Waurzyniak B; Chen H; Carpenter R; Chen CL Clin Cancer Res; 2002 May; 8(5):1224-33. PubMed ID: 12006542 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 inhibits the phospholipase D pathway stimulated by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Involvement of EP2 receptors and phosphatidylinositol 3-kinase gamma. Burelout C; Thibault N; Levasseur S; Simard S; Naccache PH; Bourgoin SG Mol Pharmacol; 2004 Aug; 66(2):293-301. PubMed ID: 15266020 [TBL] [Abstract][Full Text] [Related]
12. Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway. Altman A; Kaminski S; Busuttil V; Droin N; Hu J; Tadevosyan Y; Hipskind RA; Villalba M Eur J Immunol; 2004 Jul; 34(7):2001-11. PubMed ID: 15214048 [TBL] [Abstract][Full Text] [Related]
13. The anti-inflammatory effect of 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol by targeting Lyn kinase in human neutrophils. Liao HR; Chien CR; Chen JJ; Lee TY; Lin SZ; Tseng CP Chem Biol Interact; 2015 Jul; 236():90-101. PubMed ID: 25980585 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases. Sue-A-Quan AK; Fialkow L; Vlahos CJ; Schelm JA; Grinstein S; Butler J; Downey GP J Cell Physiol; 1997 Jul; 172(1):94-108. PubMed ID: 9207930 [TBL] [Abstract][Full Text] [Related]
16. Preclinical toxicity and pharmacokinetics of the Bruton's tyrosine kinase-targeting anti-leukemic drug candidate, alpha-cyano-beta-hydroxy-beta-methyl-N- (2,5-dibromophenyl) propenamide (LFM-A13). Uckun FM; Tibbles H; Venkatachalam T; DuMez D; Erbeck D Arzneimittelforschung; 2007; 57(1):31-46. PubMed ID: 17341007 [TBL] [Abstract][Full Text] [Related]
17. Cross-linking of CD59 and of other glycosyl phosphatidylinositol-anchored molecules on neutrophils triggers cell activation via tyrosine kinase. Morgan BP; van den Berg CW; Davies EV; Hallett MB; Horejsi V Eur J Immunol; 1993 Nov; 23(11):2841-50. PubMed ID: 7693479 [TBL] [Abstract][Full Text] [Related]
18. Rational design and synthesis of a novel anti-leukemic agent targeting Bruton's tyrosine kinase (BTK), LFM-A13 [alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide]. Mahajan S; Ghosh S; Sudbeck EA; Zheng Y; Downs S; Hupke M; Uckun FM J Biol Chem; 1999 Apr; 274(14):9587-99. PubMed ID: 10092645 [TBL] [Abstract][Full Text] [Related]